Miromatrix
Business Services · Minnesota, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
6455 Flying Cloud Dr, Eden Prairie, Minn...Phone Number
(952) 942-6000Website
www.miromatrix.comRevenue
$16.9 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Miromatrix
Miromatrix Medical Inc. is a Minnesota-based biotechnology company on a mission to save and drastically improve patients' lives by eliminating the organ transplant waiting list. Through their proprietary perfusion decellularization and recellularization technology, the company is developing fully implantable human organs including livers, kidneys, lungs and hearts.Explore more
Miromatrix Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Miromatrix your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Check if Miromatrix has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Miromatrix has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Miromatrix, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Miromatrix is spiking on competitors!
Click to see if Miromatrix had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Miromatrix
Product Launch: Get notified when Miromatrix launches new products
Earning: See what the market has to say on Miromatrix recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined Miromatrix as Masked Content
Find 2 more new buyers
Compare Similar Companies to Miromatrix
Compare insights from companies similar to Miromatrix, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
<$5M
11-50
Private
-
2016
KC
Kellie CalderonDivision Clinical Development Vice President, Medical Affairs
Company Profile Activity
Activity Insights
Miromatrix is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Miromatrix is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Miromatrix.
Miromatrix financials insights
Gather financial insights about Miromatrix, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2010
Debt
$500K
2011
Private Equity
$2M
2012
Series A
$10.3M
2013
Series B
$23.8M
2015
Private Equity
$23M
2020
Debt
$350K
2021
Series C
$27M
Miromatrix Tech Stack
A closer look at the technologies used by Miromatrix
Most Recent Scoops
Mergers & Acquisitions (M&A)
Mergers & Acquisitions (M&A)
Left Company
Executive Move
Lateral Move
Executive Move
Left Company
Executive Move
Miromatrix News & Media
United Therapeutics and Miromatrix Medical Announce Successful Tender Offer
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C. & EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR) and Miromatrix Medical Inc. (Nasdaq: MIRO) announced today the results of the previously announced tender offer by Morpheus Subsidiary Inc. (“Merger Sub”), a wholly owned subsidiary of United Therapeutics, to acquire all outstanding shares of Miromatrix for a purchase price of $3.25 per share in cash at closing and an additional $1.75 per share in cash upon thShareholder Alert: Ademi LLP investigates whether Miromatrix Medical Inc. has obtained a Fair Price in its transaction with United Therapeutics
MILWAUKEE, Oct. 31, 2023 /PRNewswire/ -- Ademi LLP is investigating Miromatrix (Nasdaq: MIRO) for possible breaches of fiduciary duty and other violations of law in its transaction with United Therapeutics. Click here to learn how to join the action...SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Miromatrix Medical Inc. Buyout
Wilmington, Delaware--(Newsfile Corp. - October 30, 2023) - Rigrodsky Law, P.A. is investigating Miromatrix Medical Inc. ("Miromatrix") (NASDAQ: MIRO) regarding possible breaches of fiduciary duties and other violations of law related to Miromatrix's agreement to be acquired by United Therapeutics Corporation. Under the terms of the agreement, Miromatrix shareholders will receive $3.25 per share in cash.To learn more about this investigation and your rights, visit:...United Therapeutics expands investment in organ manufacturing with $91M acquisition
United Therapeutics, which operates a large manufacturing facility in RTP, is expanding its research and development into organ manufacturing by acquiring Minnesota-based Miromatrix Medical.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Miromatrix
Sign Up For FreeTo access detailed company insights
Miromatrix Medical Inc. is a Minnesota-based biotechnology company on a mission to save and drastically improve patients' lives by eliminating the organ transplant waiting list. Through their proprietary perfusion decellularization and recellularization technology, the company is developing fully implantable human organs including livers, kidneys,... Read More
